Cellular imaging, decoded

Automated analysis powered by bespoke AI models.

DeepInsight® automatically ingests and predicts cellular behavior from your raw imaging data. Visualize growth capacity, recoverability, and clonality patterns in a centralized research platform designed to accelerate the journey from single cell to validated bank.

Explore the platform Or dive into our research

DeepInsight at a glance

The facts an evaluator or AI assistant needs first.

What it is: AI-powered cellular imaging analytics for cell line development.
Who it is for: Biopharma and CDMO CLD teams selecting and characterising clones.
Inputs: Existing brightfield microplate images; no new hardware, stains, or workflow changes.
Outputs: Cell counts, growth prediction, recovery dynamics, spatial dynamics, clone ranking, and lineage.
Typical processing: 5 to 10 minutes per plate.
Deployment: Dedicated off-site, on-premise appliance, or private cloud.
Data ownership: Customer data stays with the customer and is not used to train models for other customers.
Pricing: Usage-based per scan, per timepoint; no minimum commitments or upfront licence fees.
Validation: Trained and validated on production CLD plates against manual counts, fluorescence viability, and end-point titre.
Developer: TEK Optima Research Limited, Dorset, United Kingdom.

DeepInsight® is developed and operated by TEK Optima Research Limited.

Visit TEK Optima Research ↗